Notice: This company has been marked as potentially delisted and may not be actively trading. Neurotrope (NTRP) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisCompetitorsHeadlinesShort InterestTrends Neurotrope Short Interest DataNeurotrope (NTRP) has a short interest of 20,800 shares, representing 1.91% of the float (the number of shares available for trading by the public). This marks a 6.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 33,263 shares to cover all short positions.Current Short Interest20,800 sharesPrevious Short Interest19,500 sharesChange Vs. Previous Month+6.67%Dollar Volume Sold Short$39,728.00Short Interest Ratio1.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,420,000 sharesFloat Size1,090,000 sharesShort Percent of Float1.91%Today's Trading Volume8,056 sharesAverage Trading Volume33,263 sharesToday's Volume Vs. Average24% Short Selling Neurotrope? Sign up to receive the latest short interest report for Neurotrope and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNTRP Short Interest Over TimeNTRP Days to Cover Over TimeNTRP Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Neurotrope Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202420,800 shares $39,728.00 +6.7%1.9%1.3 $1.91 10/15/202419,500 shares $38,805.00 +4.3%1.8%2.6 $1.99 9/30/202418,700 shares $60,588.00 +23.8%1.7%1.8 $3.24 9/15/202415,100 shares $41,374.00 +17.1%1.4%1.2 $2.74 8/31/202412,900 shares $33,411.00 -21.3%1.2%1.1 $2.59 8/15/202416,400 shares $49,036.00 -13.7%1.3%1.3 $2.99 Get the Latest News and Ratings for NTRP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neurotrope and its competitors with MarketBeat's FREE daily newsletter. 7/31/202419,000 shares $58,140.00 -29.6%1.5%1.5 $3.06 7/15/202427,000 shares $89,370.00 No Change2.2%2 $3.31 11/15/202046,300 shares $45,161.02 -75.5%N/A0.1 $0.98 10/30/2020189,200 shares $196,768.00 +9.6%N/A0.4 $1.04 10/15/2020172,700 shares $186,516.00 +74.3%N/A0.4 $1.08 9/30/202099,100 shares $110,001.00 -36.7%N/A0.2 $1.11 9/15/2020156,500 shares $190,930.00 +66.7%N/A0.8 $1.22 8/31/202093,900 shares $101,412.00 -12.3%N/A0.3 $1.08 8/14/2020107,100 shares $118,881.00 -14.8%N/A0.3 $1.11 7/31/2020125,700 shares $143,298.00 +49.6%N/A0.3 $1.14 7/15/202084,000 shares $95,760.00 -37.8%N/A0.2 $1.14 6/30/2020135,100 shares $155,365.00 +53.2%N/A0.3 $1.15 6/15/202088,200 shares $117,306.00 -18.8%N/A0.2 $1.33 5/29/2020108,600 shares $150,964.86 +31.0%N/A0.3 $1.39 5/15/202082,900 shares $118,547.00 -36.7%N/A0.2 $1.43 4/30/2020131,000 shares $170,300.00 -17.7%N/A0.4 $1.30 4/15/2020159,100 shares $181,374.00 -15.6%N/A0.4 $1.14 3/31/2020188,500 shares $154,570.00 -46.1%N/A0.2 $0.82 3/13/2020349,900 shares $297,449.99 +1.1%3.4%1.9 $0.85 2/28/2020346,000 shares $377,140.00 -32.3%3.4%0.3 $1.09 2/14/2020510,700 shares $592,412.00 -7.7%5.2%0.5 $1.16 1/31/2020553,000 shares $641,480.00 +2.1%5.7%0.5 $1.16 1/15/2020541,700 shares $612,121.00 +0.9%5.6%0.5 $1.13 12/31/2019536,700 shares $527,146.74 -7.6%5.5%2.2 $0.98 NTRP Short Interest - Frequently Asked Questions What is Neurotrope's current short interest? Short interest is the volume of Neurotrope shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 20,800 shares of NTRP short. 1.91% of Neurotrope's shares are currently sold short. Learn More on Neurotrope's current short interest. What is a good short interest ratio for Neurotrope? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NTRP shares currently have a short interest ratio of 1.0. Learn More on Neurotrope's short interest ratio. What is a good short interest percentage for Neurotrope? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.91% of Neurotrope's floating shares are currently sold short. Is Neurotrope's short interest increasing or decreasing? Neurotrope saw a increase in short interest in October. As of October 31st, there was short interest totaling 20,800 shares, an increase of 6.7% from the previous total of 19,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neurotrope's float size? Neurotrope currently has issued a total of 1,420,000 shares. Some of Neurotrope's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neurotrope currently has a public float of 1,090,000 shares. How does Neurotrope's short interest compare to its competitors? 1.91% of Neurotrope's shares are currently sold short. Here is how the short interest of companies compare to Neurotrope: Guardion Health Sciences, Inc. (1.76%), Hepion Pharmaceuticals, Inc. (1.13%), MingZhu Logistics Holdings Limited (0.84%), Acasti Pharma Inc. (2.47%), Booking Holdings Inc. (2.41%), Expedia Group, Inc. (4.64%), XPO, Inc. (5.81%), MakeMyTrip Limited (2.81%), GXO Logistics, Inc. (2.28%), GATX Co. (4.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Neurotrope stock? Short selling NTRP is an investing strategy that aims to generate trading profit from Neurotrope as its price is falling. NTRP shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neurotrope? A short squeeze for Neurotrope occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NTRP, which in turn drives the price of the stock up even further. How often is Neurotrope's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NTRP, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Guardion Health Sciences Short Interest Hepion Pharmaceuticals Short Interest MingZhu Logistics Short Interest Acasti Pharma Short Interest Booking Short Interest Expedia Group Short Interest XPO Short Interest MakeMyTrip Short Interest GXO Logistics Short Interest GATX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NTRP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotrope, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neurotrope With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.